CD8A and neoplasm: Enrichment of Tregs inhibits CD4 + T cells, CD8 + T cells, antigen-presenting cells (APCs), monocytes, and macrophages, allowing tumor cells to proliferate more rapidly under immunosuppressive conditions [83].